CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $40,000 | +90.5% | 20,523 | +20.6% | 0.00% | – |
| Q4 2020 | $21,000 | -47.5% | 17,018 | -23.8% | 0.00% | – |
| Q3 2020 | $40,000 | -76.9% | 22,321 | +8.4% | 0.00% | -100.0% |
| Q2 2020 | $173,000 | +158.2% | 20,590 | +62.2% | 0.00% | – |
| Q1 2020 | $67,000 | -44.2% | 12,696 | -42.4% | 0.00% | -100.0% |
| Q4 2019 | $120,000 | +1.7% | 22,031 | -9.2% | 0.00% | 0.0% |
| Q3 2019 | $118,000 | -31.0% | 24,264 | -1.4% | 0.00% | 0.0% |
| Q2 2019 | $171,000 | -9.5% | 24,617 | -9.6% | 0.00% | 0.0% |
| Q1 2019 | $189,000 | +31.2% | 27,226 | +10.4% | 0.00% | 0.0% |
| Q4 2018 | $144,000 | -35.1% | 24,655 | -16.2% | 0.00% | -50.0% |
| Q3 2018 | $222,000 | +44.2% | 29,431 | -3.8% | 0.00% | +100.0% |
| Q2 2018 | $154,000 | -21.0% | 30,585 | -4.4% | 0.00% | 0.0% |
| Q1 2018 | $195,000 | -25.3% | 31,986 | -13.0% | 0.00% | -50.0% |
| Q4 2017 | $261,000 | – | 36,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |